37.01

0.70% -0.2544

Harmony Biosciences Holdings Inc (HRMY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HRMY Giù? Forum Previsione

Precedente Chiudi:

$37.26

Aprire:

$37.16

Volume 24 ore:

206.54K

Relative Volume:

0.25

Capitalizzazione di mercato:

$2.14B

Reddito:

$899.11M

Utile/perdita netta:

$145.62M

Rapporto P/E:

14.90

EPS:

2.4829

Flusso di cassa netto:

$322.54M

1 W Prestazione:

+4.70%

1M Prestazione:

+14.91%

6M Prestazione:

+0.68%

1 anno Prestazione:

+15.05%

Intervallo 1D:

$36.59

$37.35

Intervallo di 1 settimana:

$35.17

$37.40

Portata 52W:

$25.52

$40.87

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Nome

Harmony Biosciences Holdings Inc

Settore

Healthcare (1097)

Industria

Biotechnology (615)

Telefono

(484) 539-9800

Indirizzo

630 W GERMANTOWN PIKE, PLYMOUTH MEETING

Dipendente

293

Cinguettio

Prossima data di guadagno

2026-08-04

Ultimi documenti SEC

HRMY's Discussions on Twitter

Compare HRMY vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HRMY Harmony Biosciences Holdings Inc	37.00	2.11B	899.11M	145.62M	322.54M	2.4829
VRTX Vertex Pharmaceuticals Inc	526.40	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.82	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	927.48	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	314.93	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.80	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-23	Downgrade	Deutsche Bank	Buy → Hold
2026-02-23	Downgrade	Truist	Buy → Hold
2026-02-11	Ripresa	UBS	Neutral
2025-07-21	Iniziato	Truist	Buy
2025-07-10	Ripresa	Goldman	Neutral
2025-06-02	Ripresa	Oppenheimer	Outperform
2025-02-11	Iniziato	Deutsche Bank	Buy
2024-12-17	Iniziato	H.C. Wainwright	Buy
2024-10-10	Ripresa	Raymond James	Outperform
2024-09-10	Iniziato	UBS	Buy
2024-06-21	Iniziato	Citigroup	Buy
2024-01-02	Downgrade	BofA Securities	Neutral → Underperform
2023-09-25	Downgrade	Goldman	Neutral → Sell
2023-09-07	Iniziato	Berenberg	Buy
2023-04-20	Iniziato	BofA Securities	Neutral
2022-10-14	Aggiornamento	Janney	Neutral → Buy
2022-10-14	Aggiornamento	Jefferies	Hold → Buy
2022-08-03	Downgrade	Jefferies	Buy → Hold
2022-07-13	Downgrade	Goldman	Buy → Neutral
2022-07-07	Iniziato	Mizuho	Buy
2022-04-14	Iniziato	Cantor Fitzgerald	Overweight
2021-12-01	Iniziato	Oppenheimer	Outperform
2021-11-04	Iniziato	Raymond James	Outperform
2021-09-23	Iniziato	Needham	Buy
2021-03-29	Aggiornamento	Goldman	Neutral → Buy
2020-09-14	Iniziato	Goldman	Neutral
2020-09-14	Iniziato	Jefferies	Buy
2020-09-14	Iniziato	Piper Sandler	Overweight

Mostra tutto

Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie

Jul 02, 2026

HRMY growth trends beyond Wakix could shape its next growth phase - MSN

Jul 02, 2026

Jun 30, 2026

Form 144 HARMONY BIOSCIENCES HOLDINGS For: 30 June By Investing.com - Investing.com South Africa

Jun 30, 2026

Sandip Kapadia reports sale activity (HRMY) via Form 144 totaling 50,000 - Stock Titan

Jun 30, 2026

HRMY Maintained by Deutsche Bank -- Price Target Raised to $36 - GuruFocus

Jun 30, 2026

Deutsche Bank Adjusts Price Target on Harmony Biosciences to $36 From $30, Maintains Hold Rating - marketscreener.com

Jun 30, 2026

Jun 29, 2026

Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation? - TradingView

Jun 29, 2026

Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline - TradingView

Jun 29, 2026

HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase - Zacks Investment Research

Jun 29, 2026

Jun 27, 2026

HRMY Stock On Track For Best Intraday Gains In 18 Months — What Did Mizuho Analysts Say? - Stocktwits

Jun 27, 2026

Form 144 HARMONY BIOSCIENCES HOLDINGS For: 26 June By Investing.com - Investing.com South Africa

Jun 27, 2026